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Abstract
Streptococcus sanguinis is the most common cause of infective endocarditis (IE). Since the molecular basis of virulence of this
oral commensal bacterium remains unclear, we searched the genome of S. sanguinis for previously unidentified virulence
factors. We identified a cell surface ecto-59-nucleotidase (Nt5e), as a candidate virulence factor. By colorimetric phosphate
assay, we showed that S. sanguinis Nt5e can hydrolyze extracellular adenosine triphosphate to generate adenosine.
Moreover, a nt5e deletion mutant showed significantly shorter lag time (P,0.05) to onset of platelet aggregation than the
wild-type strain, without affecting platelet-bacterial adhesion in vitro (P=0.98). In the absence of nt5e, S. sanguinis caused IE
(4 d) in a rabbit model with significantly decreased mass of vegetations (P,0.01) and recovered bacterial loads (log10CFU,
P=0.01), suggesting that Nt5e contributes to the virulence of S. sanguinis in vivo. As a virulence factor, Nt5e may function
by (i) hydrolyzing ATP, a pro-inflammatory molecule, and generating adenosine, an immunosuppressive molecule to inhibit
phagocytic monocytes/macrophages associated with valvular vegetations. (ii) Nt5e-mediated inhibition of platelet
aggregation could also delay presentation of platelet microbicidal proteins to infecting bacteria on heart valves. Both
plausible Nt5e-dependent mechanisms would promote survival of infecting S. sanguinis. In conclusion, we now show for the
first time that streptococcal Nt5e modulates S. sanguinis-induced platelet aggregation and may contribute to the virulence
of streptococci in experimental IE.
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Introduction
Streptococcus sanguinis, an oral commensal bacterium, is the most
common cause of infective endocarditis (IE) [1,2]. IE is
characterized by the formation of septic thrombi or vegetations
on the heart valves. The development of IE involves bacterial
adherence, persistence and growth. Adherence is mediated by
bacterial surface molecules and host tissues [3–6]. During transient
bacteremia, adherent S. sanguinis attract monocytes and induce
them to produce tissue factor activity and cytokines, which activate
the coagulation cascade. The valve infection by S. sanguinis can also
be mediated by direct interaction with platelets in the vegetation
[3,4]. In an animal model, S. sanguinis adherence to platelets and
induction of aggregation into an in vitro thrombus correlate with
the increased severity of IE [4]. How S. sanguinis resists monocyte
engulfment, platelet killing to eventually drive the formation of
septic vegetations on heart valves remains unclear.
Among the agents known to modulate platelet aggregation are
adenine nucleotides, which are released from platelets into the
surrounding microenvironment upon stimulation with pro-throm-
botic agents [7]. Indeed, we have previously shown that dense
granules containing ATP and ADP are released from platelets in
response to S. sanguinis [8]. These nucleotides can be hydrolyzed by
S. sanguinis cell wall nucleotidase activity to modulate platelet
aggregation [9,10]. In an animal model of IE, sortase A-anchored
cell surface proteins were suggested to contribute to bacterial
virulence [11,12]. To identify the candidate enzyme, we searched
the genome of S. sanguinis SK36, and four genes containing
LPxTG motifs were found that encode putative cell surface
nucleotidases [13]. The four predicted nucleotidase products
would be anchored to the cell wall by a sortase A-dependent
mechanism [14]. One of them, ecto-59-nucleotidase (Nt5e), is a
putative surface-located enzyme that could hydrolyze extracellular
ATP, ADP, AMP to adenosine [15]. Since ADP is an agonist [16]
and adenosine is a potent platelet aggregation antagonist [17], 59-
nucleotidase activities on the surface of S. sanguinis may modulate
S. sanguinis-induced platelet aggregation and the severity of IE.
During bacterial infection, ATP and adenosine are also
important immune regulators. For example, extracellular ATP
can trigger monocyte release of proinflammatory cytokines such as
IL-1b and IL-18 [18]. In contrast, adenosine is a potent
immunosuppressive molecule, which inhibits IL-12 production,
and increases IL-10 in monocytes [19,20]. Successful host defense
balances pro- and anti-inflammatory mediators. Hence, the
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S. sanguinis Nt5e could influence the immune response during
infection. We, therefore, hypothesize that Nt5e contributes to the
virulence of S. sanguinis in IE.
To identify and characterize the enzymatic activities of Nt5e, we
have generated a nt5e deletion mutant (Dnt5e) by allelic exchange
and also complemented this strain to obtain nt5e+. We showed
S. sanguinis NT5E hydrolyzes extracellular ATP to generate
adenosine. Using platelet aggregation and platelet-bacterial
adhesion assays, we also showed that Nt5e delayed S. sanguinis-
induced human platelet aggregation without affecting platelet-
bacterial adhesion. Finally, Nt5e was determined to be a plausible
virulence factor in a rabbit endocarditis model.
Results
Identification of the S. sanguinis Protein Possessing Cell
Surface Nucleotidase Activity
By mining the SK36 genome, 16 putative surface proteins with
LPxTG motifs were identified. Of these proteins, we identified
four putative cell-surface nucleotidases based upon the presence of
an LPxTG motif and substrate specificities that suggest the ability
to hydrolyze a nucleotide and water to a nucleoside and
orthophosphate (Table S1). Putative Nt5e showed a substrate
specificity that would most likely hydrolyze released platelet
adenine nucleotides and yield adenosine. To test this possibility in
strain SK36, allelic exchange mutants of nt5e and the other
putative nucleotidases were each constructed using primers listed
in Tables S3 (SK36) and compared for loss of hydrolysis of
extracellular adenine nucleotides (Figure 1). Each strain was
incubated with 10, 50, or 100 mM of ATP, ADP or AMP.
Hydrolysis is reported as S. sanguinis Nt5e activity per cell. When
strain SK36 was compared to deletion mutants of genes for the
extracellular nuclease (nucH), cyclo-nucleotide phosphodiesterase
(cnp) or DNA repair ATPase (rad3), only Dnt5e cells lost significant
ability of whole cells to hydrolyze ATP (Figure 1A, P,0.05), ADP
(Figure 1B, P,0.05) and AMP (Figure 1C, P,0.05) at each
concentration examined. The ATPase, ADPase and AMPase
activities of Dnt5e cells were also associated with a reduction in the
lag time to platelet aggregation (Figure S1).
Characterization of the Enzymatic Activities of
S. sanguinis 133-79 Nt5e
Platelets from some donors do not aggregate in response to strain
SK36, reflecting donor specificity [21]. To determine whether the
enzymatic activities were expressed by other platelet-aggregating
strains, we also studied S. sanguinis 133-79. Whole cells of S. sanguinis
133-79 wild-type (wt) hydrolyzed the adenine nucleotides ATP




mutant was restored to wt levels by complementation (nt5e+)
(Figure2A).Intheabsenceofnt5e,theADPaseactivitywasreduced,
whereas activity in this mutant was restored to wt levels by
complementation (nt5e+) (Figure 2B). Similarly, AMPase activity in
S.sanguinis133-79wasfullyabrogatedbydeletionofnt5e(Figure2C).
Whencomplemented,nt5e+regainedAMPaseactivity.Indeed,Dnt5e
generated inorganic phosphate only with ATP as substrate, which
mayreflectactivityofanecto-ATPaseonthecellsurfaceofS.sanguinis
aswereported[9].WhencomparedtoNT5E,ecto-ATPaseactivity
did not play a major role in the hydrolysis of extracellular adenine
nucleotides.Collectively,theseresultssuggeststronglythatNt5eonS.
sanguinis 133-79 hydrolyzes the adenine nucleotides ATP, ADP and
AMP.
AMPase Activity Attributed to Nt5e
WefocusedontheabilityofS.sanguinistoproduceadenosine,which
couldpotentiallyaffectthecourseofexperimentalendocarditis.Since
our assays were performed with whole cells, we considered the
possibility that total enzyme activity could include other phospha-
tases. A search of the S. sanguinis genome suggested the possible
expression of two putative alkaline phosphatase (AP) ectoenzymes
[13].TobetterdefinetheenzymesresponsibleforwholecellAMPase
activity, the assay was run in the presence of a,b-methylene ADP
(APCP), a known inhibitor of Nt5e [22] (Figures 2D and 2E). When
expressedonalogarithmicscale,theAPCPdose-inhibitioncurvewas
fitted to a sigmoidal, single-site model (Figure 2D), allowing
determination of the half-maximal inhibitory concentration
(IC50=8.863.8 mM). In the presence of APCP
(Km=66.7614.1 mM; Vmax=0.960.1 nmoles Pi/min per
10
6 cells), the whole cell AMPase activity showed an apparent
increase in Km (P,0.05), but no increase in the Vmax (P=0.3)
compared to the no inhibitor control (Km=38.9615.6 mM;
Vmax=1.060.2 nmoles Pi/min per 10
6 cells). Since the inhibition
could be overcome at high concentrations of AMP substrate, APCP
competitively inhibited AMPase activity (Figure 2E). Furthermore
unlike Nt5e, AP is sensitive to an alkaline pH optimum [23]. In S.
sanguinis 133-79, the AMPase activity did not significantly increase
with increasing pH (Figure 2F). Therefore, the AMPase activity was
not AP,but attributable to Nt5e.
Identification of Nt5e as a Cell-surface Protein from
S. sanguinis
To show that Nt5e is a cell wall-associated enzyme, we
characterized a cell surface protein fraction with the requisite
enzyme activities. Recovery of the cell surface proteins fragments
from S. sanguinis 133-79 was maximal after 7 minutes of TPCK-
trypsin digestion (data not shown). The 7-minute tryptic digests
(crude digest) of S. sanguinis 133-79 were chromatographed on a
column of Sephadex G-100, pooled (Figure 3A), fractions resolved
using SDS-PAGE (Figure 3B), and analyzed for platelet interac-
tions (Table 2). Fraction 3 (G100-3) had the greatest ability to
inhibit S. sanguinis-induced platelet aggregation, but had no effect
on platelet-S. sanguinis adhesion (data not shown). After separation
of Fraction 3 by two-dimensional SDS gel electrophoresis and
analysis by mass spectrometry, two putative 59-nucleotidase
superfamily proteins were identified (Table 3) [13]. The crude
digest and fraction G100-3 showed 59-nucleotidase activities
(Table 2). Compared with the crude digest, G100-3 had higher
ATPase, ADPase and AMPase activities, which correlated with the
inhibition of platelet aggregation (Table 2). In the plasma, both
ADP removal and adenosine generation can inhibit platelet
aggregation [24]. Taken together, 59-nucleotidase is a protein
cleaved from the surface of S. sanguinis 133-79, which appeared to
metabolize adenine nucleotides to modulate platelet aggregation.
Inhibition of Platelet Aggregation by Nt5e
We next compared whole cells of S. sanguinis 133-79 wt, Dnt5e
and nt5e+ strains for the ability to induce platelet aggregation. In
response to either wt or nt5e+, platelets from a representative
donor aggregated in approximately 9 minutes (Figure 3C). The
aggregation response of Dnt5e showed a lag-time of approximately
5 minutes, which was significantly shorter than the wt and nt5e+
Ecto-59-Nucleotidase in Endocarditis
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similar in response to all three strains (Figure 3C). The aggregation
responses to S. sanguinis 133-79 wt, Dnt5e and nt5e+ were consistent
for all three platelet donors tested (data not shown). Similar results
were obtained using S. sanguinis SK36 (Figure S1). Therefore,
S. sanguinis Nt5e prolonged the lag time to the onset of platelet
aggregation.
Adhesion of Platelets and Bacteria
Since the ability to induce aggregation is a function of adhesion
of S. sanguinis to platelets [25], we next sought to determine
whether deletion of NT5E affected aggregation because adhesion
was affected. The percent adhesion to platelets was similar for wt
(133-79: 60.160.9%; SK36: 60.161.9%), Dnt5e (133-79:
59.961.2%; SK36: 56.561.4%) and nt5e+ (133-79: 59.662.6%)
strains. Hence, NT5E modulates platelet aggregation without
affecting adhesion.
Figure 1. nt5e confers Nt5e activity on S. sanguinis SK36 whole cells. Nt5e activity was measured by the release of inorganic phosphate (Pi)
from adenine nucleotides. (A), (B), and (C) were showed as enzyme velocity vs. concentration of ATP, ADP and AMP substrates, where the results were
represented as mean6SE, n=3. Statistical analysis was performed by one-way ANOVA with Dunnett’s post-test for multiple comparisons.
*significantly decreased compared to wild-type strain SK36 (P,0.05). Dnt5e:5 9-nucleotidase deletion mutant; DnucH: extracellular nuclease deletion
mutant; Dcnp: cyclo-nucleotide phosphodiesterase deletion mutant; and Drad3: DNA repair ATPase deletion mutant.
doi:10.1371/journal.pone.0038059.g001
Table 1. Characterization of the enzymatic activities of S. sanguinis 133-79 Nt5e.
Substrate ATP ADP AMP
Km
a Vmax
b Km Vmax Km Vmax




nt5e+ 124.7633.8 8.360.9 81.7621.1 5.460.5 40.067.2 0.960.1
abEnzyme parameters were calculated by nonlinear curve fitting using GraphPad Prism. Km was represented as mean.
6SE mMa n dV max was represented as mean6SE nmoles Pi/min per 10
6 cells.
cStatistical analysis was performed using ANOVA, and followed by Bonferroni test. Significant differences were only. obtained when comparing wt and Dnt5e, P,0.01.
doi:10.1371/journal.pone.0038059.t001
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Rabbit Infective Endocarditis
To investigate the contribution of Nt5e to S. sanguinis virulence
in infective endocarditis, rabbits with experimental heart valve
injury were infected by intravenous inoculation with 1610
9 CFU
S. sanguinis 133-79 wt, Dnt5e,o rnt5e+. Growth curves in TH broth
were performed for all three strains to test for changes in cell
growth or fitness. Although the nt5e deletion mutant showed a
slight delay in entry to log-phase, all strains displayed similar
growth rates in TH broth maintained in air with 5% CO2 (not
shown). The resulting vegetations ranged from non-apparent
(Figure 4A) to macroscopic lesions (Figures 4B and 4C).
Four days after inoculation with S. sanguinis, bacterial load
recovered from the vegetations ranged from 10
3 to 10
9 per rabbit;
the vegetative masses correlated with the recovered bacterial
CFUs (Figure 4D; R
2=0.66, n=31). Eight of 31 infected rabbits
had no visible vegetations, which might due to insignificant injury
caused by catheter placement. Total recovered bacterial CFUs
indicated the relative ability of each strain to colonize and
proliferate on the heart valve.
As expected, 11 out of 12 rabbits infected with wt formed aortic
vegetations with a mean mass of 18.6 mg and mean recovered
bacterial load of 1.0610
8 CFU. Similarly, after infection with
nt5e+, vegetations formed in 7 of 8 rabbits with a mean mass of
12.5 mg and mean bacterial load of 0.2610
8 CFU on TH plates,
and 0.3610
6 CFU on TH plates with appropriate antibiotics. The
CFUs recovered with and without antibiotics were not significantly
different. In contrast, 6 of 11 rabbits injected with Dnt5e showed no
vegetations. Two other rabbits died before euthanasia and were
excluded from statistical analysis. In rabbits challenged with Dnt5e,
the mean weight of vegetations was 4.0 mg and the mean bacterial
load was 0.7610
6 CFU on non-selective and 0.1610
6 CFU on
selective plates, which were the lowest infectious loads among
these three groups. Taken together, Dnt5e-infected rabbits
Figure 2. Characterization of Nt5e activity on S. sanguinis 133-79 whole cells. Nt5e activity was measured by the release of inorganic
phosphate (Pi) from adenine nucleotides. For (A), (B), and (C), the Michaelis-Menten curves were showed as enzyme velocity (represented as nmole/
min/10
6 cells) vs. concentration of ATP, ADP and AMP substrates. (D) Effect of Nt5e inhibitor APCP on AMPase activity of S. sanguinis 133-79. The
curve was fitted to a sigmoidal inhibitory dose-response curve and the inhibitory concentration 50% (IC50) value derived from the curve fit was
shown. (E) Michaelis-Menten curves of AMPase activity vs. substrate concentration in the absence and presence of APCP. (F) pH dependence of
AMPase activity of Nt5e. Statistical analysis was performed using non-linear regression. The results were represented as mean6SE, n=3; *significantly
decreased compared to no inhibitor (P,0.05).
doi:10.1371/journal.pone.0038059.g002
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a AMP ADP ATP
None – 7.5 – – –
Crude digest 6.4 9.8 0.15 0.12 0.11
Fraction 1 1.3 (20.3) 7.5 0.01 0.01 0.01
Fraction 2 1.7 (26.6) 7.8 0.12 0.10 0.09
Fraction 3 1.0 (15.6) .30 0.59 0.55 0.42
Fraction 4 0.8 (12.5) 7.6 0.01 0.01 0
Fraction 5 0.8 (12.5) 7.5 0.02 0 0
Recovered total 5.6 (87.5)
aPRP was preincubated with the indicated fraction at a final concentration of 0.1 mg/ml.
bProteins were incubated with 50 mM of AMP, ADP or ATP for 15 minutes at 37uC at a final concentration of 10 mg/ml.
doi:10.1371/journal.pone.0038059.t002
Figure 3. Nt5e is a trypsin-cleavable surface protein of S. sanguinis and affects platelet aggregation lag time. (A) Gel filtration
chromatography of 7-minute tryptic digest of S. sanguinis 133-79. 6.4 mg was placed on a column of Sephadex G-100 and chromatographed as
described under ‘‘Materials and methods’’. (B) SDS-PAGE analysis of S. sanguinis tryptic digest fractions from gel filtration chromatography. All
samples contained 15 mg of protein solubilized in 1% (w/v) SDS sample buffer. These samples were electrophoresed on a 10% gel, and stained with
Coomassie Blue. Lane A, trypsin. Lane B, flow-through from void volume. Lane C, starting 7-minute crude tryptic digest. Lane D, Sephadex G-100
fraction 1. Lane E, Sephadex G-100 fraction 2. Lane F, Sephadex G-100 fraction 3. Lane G, Sephadex G-100 fraction 4. Lane H, Sephadex G-100 fraction
5. (C) PRP was stirred in an aggregometer. Wild type and Dnt5e strains were added at the S. sanguinis 133-79-labeled arrowhead and aggregation was
measured as increasing light transmission. The start of aggregation of each strain was indicated by arrow. The aggregation tracing in response to the
nt5e+ strain (not shown) was indistinguishable from the wild type. (D) Response leading to aggregation was recorded as the mean lag-time to onset
of aggregation6SE, N=4; Statistical analysis was performed using one-way ANOVA with Tukey-Kramer post-test for multiple comparisons. *
significantly decreased compared to wt (P,0.05).
doi:10.1371/journal.pone.0038059.g003
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significantly lower bacterial CFUs (P=0.01) than rabbits chal-
lenged with the wt strain. Notably, the Dnt5e group showed an
approximately 100-fold reduction in mean CFUs as compared
with the wt group (Figure 4E). After rescuing the nt5e gene, nt5e+
and wt infected rabbits showed comparable aortic vegetations
(P=0.32) and bacterial CFUs (P=0.55).
Discussion
For the first time, we present data that strongly suggests S.
sanguinis Nt5e contributes to virulence during experimental IE in
rabbits. This cell surface enzyme can hydrolyze ATP to adenosine,
which slows the platelet aggregation response in vitro and may
reduce the accumulation of platelets on infected heart valves in
vivo. As a surface protein, Nt5e could also be involved in
adherence to platelets or platelet vegetations and contribute to
nutrient acquisition (i.e., nucleosides) and the persistence of
infection. Other than adenosine production, these explanations
appear unlikely. In the presence and absence of Nt5e, adhesion of
S. sanguinis to platelets is similar as we show, and growth and
biofilm formation were also comparable (data not shown). It is
more plausible that during IE adenosine is produced to inhibit
Table 3. Proteins in G100-3 identified by mass spectrometry.
Identified protein Accession No. ID Probability Putative substrate specificity
59-nucleotidase, putative (S. sanguinis SK36) gi|125718054 95% 59-nucleotides with preference for adenine nucleotides
Cyclo-nucleotide phosphodiesterase (S. sanguinis SK36) gi|125717119 100% Nucleoside 29,39-cyclic phosphate into nucleoside 39-
phosphate
Cyclo-nucleotide phosphodiesterase (S. suis 98HAH33) gi|146321945 100% Nucleoside 29,39-cyclic phosphate into nucleoside 39-
phosphate
59-nucleotidase family protein (S. gordonii CH1) gi|157150885 99% 59-nucleotides with preference for adenine nucleotides
doi:10.1371/journal.pone.0038059.t003
Figure 4. Nt5e affects vegetation weight and bacterial load in a S. sanguinis rabbit endocarditis model. (A) Aortic valve of a rabbit
infected with S. sanguinis 133-79 Dnt5e. The aortic valve is composed of three leaflets, no visible vegetations were found and 2.5610
3 CFUs were
recovered. (B) Aortic valve of a rabbit infected with S. sanguinis 133-79 nt5e+, with one vegetation in the center leaflet (white circle) and 3.3610
8 CFUs
were recovered. (C) Aortic valve of a rabbit infected with S. sanguinis 133-79 wt, with two vegetations on center and right leaflets (white circle),
respectively and 3.4610
9 CFUs were recovered. (D) Plot of vegetation bacterial load (total CFU) versus vegetation mass. All vegetations on the aortic
valve of each rabbit were pooled to obtain the vegetation weight and bacterial load (on TH plate). When no vegetations were found, the valves were
scraped with a blade and plated to determine the valve bacterial load. R
2=0.66 (n=31) indicated that there is a correlation between the bacterial
load and vegetation masses. (E) Bacterial loads in the rabbit endocarditis model, enumerated as log10 total CFU 4 days after infection. Statistical
analysis was performed using one-way ANOVA with Tukey-Kramer post-test. Horizontal bars represent mean CFUs in each cohort.
doi:10.1371/journal.pone.0038059.g004
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pressive agent. In this context, immunosuppressive adenosine has
recently been implicated in other infections caused by bacteria
including Staphylococcus aureus, Bacillus anthracis and also the
protozoan parasite Leishmania [26–28]. Since Nt5e is widely
conserved, the hydrolysis of ATP to immunosuppressive adenosine
in vivo may be relevant to the virulence of infection by many
species. Direct evidence for the role of adenosine produced by
Nt5e during infection is needed.
As a potent immunoregulator of inflammation, adenosine
inhibits the proinflammatory and promotes anti-inflammatory
actions of immune cells via four specific cell surface receptors: A1,
A2a,A 2b, and A3 [29]. For example, in human and mouse
monocytes/macrophages, the engagement of adenosine receptors,
particularly A2a receptors, by adenosine or its analogues inhibits
the production of IL-12 and TNF-a, two proinflammatory
cytokines, and increases IL-10, a protective cytokine that
suppresses IL-12 and TNF-a [19,20,30–32].
To understand the mechanism by which adenosine is produced,
we began with our earlier observation that nucleotidase activity is
expressed on the cell wall of S. sanguinis [9,10]. The fact that the
Nt5e deletion mutant possesses ATPase activity at higher ATP
concentrations suggests a contributory role of the ecto-ATPase
(higher Km) in the hydrolysis of ATP. In the present report, we
distinguish the ecto-ATPase activity from Nt5e. We characterized
nucleotidase activities associated with whole cells and showed that
adenosine was the product of Nt5e hydrolysis of ATP, ADP or
AMP in vitro. For each substrate, hydrolysis by whole cells
followed Michaelis-Menten kinetics and could not be attributable
to other enzyme activities associated with phosphate hydrolysis.
These results and analysis of the published genome of strain SK36
and our partially sequenced strain 133-79, led us to hypothesize
that the surface nucleotidase activities were attributable to a single
surface enzyme, Nt5e on S. sanguinis.
To explore the possibility that adenosine-producing activity
could resolve to a single protein, Nt5e was cleaved from the cell
surface of S. sanguinis 133-79 by mild trypsin digestion. When the
digest was fractionated using gel filtration chromatography, Nt5e
largely resolved in one of the fractions, G100-3, and its presence
was confirmed by mass spectroscopic analysis. The possibility that
other enzymes detected in this fraction could mimic Nt5e activity
was systematically excluded. Since Nt5e can hydrolyze ATP and
ADP, an agonist of platelet aggregation, and generate adenosine,
an inhibitor of platelet aggregation, it was not surprising that
fraction G100-3 inhibited platelet aggregation. Nt5e contains an
LPxTG-motif, which is characteristic of cell wall bound surface
proteins in Gram-positive bacteria [14]. Given that enzyme
activity is also expressed on intact, viable whole cells of S. sanguinis,
Nt5e is an ecto-enzyme. Since the Dnt5e strain was unable to
hydrolyze the nucleotides to adenosine, the data strongly suggest
that cell-surface Nt5e activity modulates platelet aggregation by
producing adenosine from related nucleotides.
In the absence of nt5e, the ATP and ADP released from platelet
dense granules are not hydrolyzed, adenosine is not produced and
the lag time to the onset of platelet aggregation is shortened. We
largely ruled out that the loss of surface Dnt5e affected interactions
with the platelet surface since this mutant showed platelet adhesion
similar to the wild-type strain. In the interactive microenvironment
with platelets, S. sanguinis induces release of ATP and ADP from
platelet dense granules [9,10]. S. sanguinis Nt5e is, therefore,
strongly suggested to hydrolyze ATP and ADP released from
dense granules and produce aggregation inhibitor adenosine to
modulate aggregation responses.
In IE, the ability of S. sanguinis to induce platelet aggregation in
vitro is directly related to the mass of developing thrombotic
vegetations on heart valves in vivo [4–6,33]. Using a rabbit
endocarditis model, we compared the virulence of S. sanguinis 133-
79 wt, Dnt5e, and nt5e+ in vivo. Virulence was reflected by the
weight of resulting cardiac vegetations and bacterial burden
[4,34]. The mass of the vegetations was directly related to the
CFUs of bacteria colonizing the vegetations (R
2=0.66, n=31)
when total CFUs of all strains were enumerated on non-antibiotic-
containing plates. In Dnt5e challenged rabbits, the mass of the
vegetations and recovered bacterial CFUs were 100-fold lower
than in wt infected rabbits. When complemented, nt5e+ and wt
infected rabbits showed comparable aortic vegetations and
bacterial CFUs on plates with no antibiotics. Based on these data,
nt5e appears to be responsible for the increased virulence of the
wild-type and complemented strains.
Differences in vegetation formation and recovery of CFUs from
the heart valves of infected rabbits may reflect strain-specific
efficiency in bacterial clearance from heart valves. When Nt5e was
expressed by infecting wt and nt5e+ strains, adenosine produced in
the vegetation microenvironment could inhibit phagocytosis by
infiltrating monocytes/macrophages to facilitate colonization [35].
The concentrations of locally available adenosine would be higher
than in vegetations from the Dnt5e group, which showed
attenuated vegetation formation and lower recovered CFUs. In
addition, wt and nt5e+ strains would hydrolyze ATP in the
microenvironment. Extracellular ATP, a proinflammatory signal,
can be sensed by purinergic P2Y receptors, which are highly
expressed on immune and non-immune cells [36]. On endothelial
cells and monocytes, stimulation with extracellular ATP leads to
the release of proinflammatory cytokines such as IL-1b and IL-12
[18,20,37]. When ATP is hydrolyzed and adenosine is generated,
proinflammatory activity would be expected to be lost and
immunosuppressive activity produced. Therefore, Nt5e potentially
promotes bacterial survival through ATP removal and adenosine
generation. How nt5e might contribute, however, to bacteria-
monocyte interactions remains to be established. We await further
direct evidence for the role of Nt5e nucleotidase activities in IE; a
catalytic mutant of Nt5e will be informative when developed.
Nt5e could also play another role in the formation of
vegetations in vivo. Both rabbit [38] and human platelets [39]
release platelet microbicidal proteins (PMPs) and thrombin-
inducible PMPs (tPMPs) in vitro. The PMPs and tPMPs can both
kill [40] and exert nonlethal anti-adherence effects [41] against a
wide spectrum of endovascular pathogens, including viridans
streptococci [40]. Since the Dnt5e strain induced platelet aggrega-
tion faster than S. sanguinis isogenic wild-type strain, without
affecting bacterial-platelet adhesion, release of PMPs would also be
affected. In IE, the Dnt5e strain might thwart early infection more
efficiently than when nt5e is expressed. With less time for growth
and doubling of the infecting bacteria, the mass of the vegetation
and eventual bacterial load will be lower than in the presence of
NT5E. Using two plausible mechanisms, therefore, Nt5e may
contribute to the bacterial survival in the blood, persistence in the
vegetation, and virulence of the organism.
In a rabbit IE model, Turner et al. [12] reported that a nt5e
transposon mutant of S. sanguinis SK36 and the parental strain
were equally competitive. These findings differed from our own.
The different findings may reflect the study designs, including
implementation of the animal model, the difference in the
construction of the mutant, the inoculum size, and the duration
of infection.
Of note also, some rabbits developed lung congestion. During
IE, formation of large aggregates of bacteria and platelets would
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[4,33]. However, lung congestion did not appear to be associated
with nt5e or size of vegetation (data not shown).
Note also that the bacterial counts from rabbits infected with
Dnt5e were not significantly different, based on CFUs recovered
from antibiotic-containing and non-antibiotic plates. Plating
efficiency was similar. For rabbits infected with nt5e+, less than
1% of the post-infection bacteria enumerated from the vegetations
appeared to retain the complemented plasmid, indicating antibi-
otic resistance tended to be cured without the selective pressure of
the specific antibiotics. The vegetation masses and bacterial CFUs
recovered from non-antibiotic plates of nt5e+ and wt groups were
comparable, however, suggesting that nt5e+ loses the comple-
mented plasmid gradually during the course of infection. These
results suggest that the impact of Nt5e on the persistence of S.
sanguinis in the infected vegetation may be underestimated by our
studies.
In summary, we have shown that Nt5e possesses specific
nucleotidase activity, which can influence platelet aggregation by
the production of adenosine. Adenosine is likely to influence the
outcome of Streptococcus sanguinis infection. To show that specific
nucleotidase activity of Nt5e is a contributory factor towards the
development of infective endocarditis, specific enzymatic activity
must be mutated within the surface enzyme. In our animal model
of endocarditis, we did show that Nt5e deletion attenuates
virulence. We cannot completely exclude the possibility, however,
that Nt5e may possess other properties that contribute towards this
phenotype. Cell-surface Nt5e activities are widely distributed
among bacteria including Staphylococcus aureus [42], Helicobacter pylori
[43] and S. gordonii [44]. The platelet modulating effects of Nt5e
might be a common mechanism among S. sanguinis strains, and
perhaps other bacterial pathogens, such as staphylococci and
enterococci, which cause blood borne infections. Indeed, AMPases
on pathogens like Staphylococcus epidermidis and Enterococcus faecilis
can generate immunosuppressive adenosine [28]. Therefore, the
nucleotidase activity of Nt5e is suggested to be a common
virulence factor for the survival of bacterial pathogens in the
blood.
Materials and Methods
Bacterial Strains and Culture Conditions
S. sanguinis strains were routinely grown in Todd Hewitt broth
(TH broth, Difco; Sparks, MD) or on TH agar plates at 37uCi n
5% CO2. E. coli cells were grown aerobically at 37uC in Luria-
Bertani broth (LB broth, Bacto; Sparks, MD). When required,
antibiotics were added to the medium at the indicated concentra-
tions: erythromycin (Em), 10 mgm l
21 (S. sanguinis); and kanamycin
(Km), 50 mgm l
21 (E. coli) or 400 mgm l
21 (S. sanguinis).
Genetic Manipulations in S. sanguinis
Standard recombinant DNA techniques were employed as
described [43]. Plasmids (listed in Table S2) were purified from
E. coli cells using the QIAquick Spin Miniprep purification Kit
(Qiagen Inc., Valencia, CA). Oligonucleotides for strain SK36
(Table S3) and 133-79 (Table S4) were synthesized for deletion (A1
and A2) and complementation (ACom) using integrated DNA
Technologies.
Chromosomal DNA was prepared from mutanolysin-treated
streptococcal cells using the Qiagen 100/G Genomic Tip system
[45].PCRproductswerepurifiedusingtheHighPurePCRProduct
PurificationKit(RocheLtd.,Indianapolis,IN).DNArestrictionand
modification enzymes were used according to the manufacturer’s
directions (New England BiolabsInc.,Ipswich, MA).
The target genes of S. sanguinis (wt) were inactivated by allelic





fused construct was then PCR-amplified, purified and transformed
into wt. For transformation, overnight cultures were grown in TH
broth. The next day, cells were inoculated into fresh aliquots of the
same medium (1:40), containing 10% heat-inactivated horse serum
(Sigma-Aldrich, St. Louis, MO), and the fused DNA construct was
added. Competence stimulating peptide (CSP, a gift from Dr. Jens
Kreth,UniversityofOklahoma)wasaddedtoafinalconcentrationof
200 ng ml
21. Incubation continued for 5 h at 37uC and cells were
plated on Em selective TH plates, generating the deletion mutant.
ThemutationwasconfirmedbyPCRamplificationandsequencing.
To complement the deletion mutant, a DNA fragment
encompassing the entire target gene and upstream promoter
sequence was amplified by PCR from wt and cloned into the
E. coli-streptococcal shuttle vector pDL276 [48], generating
plasmid pDL276-gene. The construct was amplified in E. coli,
purified and used to transform the deletion mutant to obtain the
complemented strain using the method described above.
Nucleotidase Activities
Streptococcal cells in stationary phase were harvested from
overnight cultures. Harvested cells were washed twice with 30 mM
TrisNHCl buffer (pH 7.4) containing 0.25 mM ethylenediamine-
tetraacetic acid (EDTA) and 30 mM sodium chloride (NaCl),
followed by washing with 50 mM TrisNHCl (pH 7.4) containing
130 mM sodium chloride (NaCl) and 5 mM magnesium dichlo-
ride (MgCl2), and resuspended to 2610
9 cells per ml. For
phosphate hydrolase activity, streptococcal cells were washed
twice with 50 mM TrisNHCl (pH 8.0) buffer containing 150 mM
NaCl, 5 mM CaCl2, and 5 mM MgCl2. The bacterial suspension
(0.5 ml) was mixed with AMP at final concentrations up to
100 mM in a 2 ml microcentrifuge tube, or with up to 400 ml ADP
or ATP, and incubated at 37uC for 30 minutes. After incubation,
cells were centrifuged at 10,0006g for 5 minutes, and 50 ml of the
supernatant was transferred into 96-well plates (Corning, N.Y.).
Similarly, the crude tryptic digest or fractions from gel filtration
(final concentration 10 mg/ml) were incubated with 50 mM AMP,
ADP or ATP at 37uC for 15 minutes. The reactions were stopped
with an equal volume of HCl (final concentration 0.1N). The final
solution (50 ml) was then transferred into 96-well plates. The
enzymatic activity was measured as the amount of inorganic
phosphate (Pi) released into the supernatants using the Quanti-
Chrom Phosphate Assay Kit DIPI-500 (Bioassay systems, Hay-
ward, CA). The results were expressed as nM of Pi produced/min
per 10
6 cells or nM of Pi produced/min per ng of protein. The Km
(Michaelis constant) and Vmax (maximum velocity) for AMPase
activity of intact S. sanguinis cells were calculated from substrate
concentration curves using nonlinear regression of four replicates
for each concentration point. To minimize the likelihood that Pi
was generated by other enzymes, some streptococcal cells were
pretreated with 1 mM to 1 mM tetramisole (Sigma-Aldrich, St.
Louis, MO), an inhibitor of alkaline phosphatase, or 1 mMt o
1 mM adenosine 59-[a,b-methylene] diphosphate (APCP) (Sigma-
Aldrich, St. Louis, MO), an inhibitor of mammalian Nt5e, before
incubating with AMP.
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Fractions
Minimal tryptic digests of S. sanguinis 133-79 were prepared as
described [49], which leaves the cell wall intact. The crude digests
representing minimally digested surface proteins were concentrat-
ed and desalted using an ultrafiltration column (10 kDa cutoff;
Millipore, Billerica, MA) into 2 mL deionized water (dH2O). The
salt-free protein fragment concentrates were then chromato-
graphed on a column (1.25695 cm) of Sephadex G-100 (GE
Healthcare, Pittsburgh, PA) at a flow rate of 0.3 ml/min in PBS.
The fraction with the greatest ability to inhibit S. sanguinis-induced
platelet-rich plasma (PRP) aggregation (G100-3) was then
analyzed using two-dimensional SDS gel electrophoresis. Gels
were stained with silver stain and spots were excised for mass
spectrometry analysis (Center for Mass Spectrometry and
Proteomics, University of Minnesota).
Platelet Aggregometry
Strains of S. sanguinis were tested for the ability to induce platelet
aggregation using fresh PRP obtained from a single donor as
described previously [24]. A single donor was used to eliminate
variability in platelet response between donors [21] and the
procedures were reviewed and approved by the IRB of the
University of Minnesota. Each bacterial strain (50 ml suspension
containing 4610
9 cells/ml) was incubated with 450 ml of PRP
(4610
8 cells/ml). PRP aggregation was performed at 37uC with
controlled stirring in a recording aggregometer (model 660,
Chronolog Corp., Havertown, PA), and the lag time or delay to
onset (minutes) was measured.
Platelet Bacterial Adhesion Assay (PBAA)
All procedures were performed as described previously [24]. In
brief, platelets from outdated PRP (Memorial Blood Center, St.
Paul, MN) were washed with PBS and fixed with 10% formalin.
Washed platelets and washed streptococcal cells were incubated
together or alone (controls) in microwells; the small clusters of
adhering platelets and bacteria were separated from non-
interacting particles by centrifugation. The sedimentation of
adhering mixtures relative to controls was quantitated by the
following formula: percent adhesion=1006{1–[mixture A620 nm/
(bacterium A620 nm+washed-platelet A620 nm)/2]}. Based on
previous studies of the variability of the method, only adhesion
scores of $20% were considered positive.
Experimental Endocarditis Model
Injury-induced experimental endocarditis was initiated by
placement of a catheter into the left side of the heart in healthy,
adult New Zealand White rabbits (2 to 3 kg; obtained from
Bakkom Rabbitry, Red Wing, MN), essentially as described
previously [4,34]. The procedures were reviewed and approved by
the IACUC of the University of Minnesota. The catheter was
retained in place for 2 hours to abrade the heart valve and then
removed. After closure of the neck incision, viable S. sanguinis was
injected intravenously via the marginal ear vein. A total of 33
rabbits were inoculated with 1610
9 of S. sanguinis 133-79 wt
(n=12 rabbits), nt5e deletion mutant (Dnt5e) (n=13) and
complemented strain (nt5e+) (n=8). After four days, the animals
were euthanized, hearts were removed, aortic valves were excised
and vegetations were weighed. To determine infecting bacterial
colony forming units (CFUs), vegetations from each rabbit were
homogenized separately in 1 ml of TH broth and plated onto TH
agar and CFUs were enumerated.
To determine whether antibiotic resistance markers were lost
during the four-day infection in vivo without antibiotics, samples
from vegetations were also enumerated on replica plates with
appropriate antibiotics. For Dnt5e, the CFUs on TH plates with or
without antibiotics were not significantly different (P=0.25),
indicating that resistance markers were retained. In contrast, the
nt5e+ group tended to show reduced growth on antibiotic-
containing medium (P=0.15), suggesting loss of the complemen-
tation plasmid. Less than 1% of the bacteria enumerated from the
nt5e+ group still retained the complemented plasmid.
When vegetations were not visualized, all of the aortic valve
leaflets were scraped and cultured to enumerate the bacteria
colonizing the valves. Since all bacteria recovered from the aortic
valve potentially contributed to the infection and vegetation
formation, CFUs on TH plates without antibiotics were used for
statistical analysis. All experiments were conducted under the
established guidelines of the University of Minnesota Institutional
Animal Care and Use Committee.
Gene Sequences
We have partially sequenced the genome of S. sanguinis 133-79.
The putative nt5e gene of S. sanguinis 133-79 and S. sanguinis SK36
[13] shared 95% sequence identity. The annotated genome of S.
sanguinis SK36 (NC_009009) is available at http://www.ncbi.nlm.
nih.gov. The GenBank accession number for the S. sanguinis 133-
79 nt5e gene is BankIt1529021 Seq1 JQ920433.
Statistical Analysis
Descriptive statistics, including the means and standard errors,
were calculated. Total CFUs were converted to log10 values prior
to statistical analysis. Statistical analysis of data was performed
using the Student’s t-test, one-way analysis of variance (ANOVA),
non-linear regression or 4-parameter logistic regression (4-PL) with
GraphPad Prism 5 (GraphPad Software, La Jolla, CA). An
a=0.05 was considered to be statistically significant.
Supporting Information
Figure S1 NT5E affects platelet aggregation lag time in
response to S. sanguinis SK36. Response leading to
aggregation was recorded as the mean lag-time to onset of
aggregation6SD, N=2.
(TIF)
Table S1 S. sanguinis SK36 cell-surface proteins poten-




Table S2 Bacterial strains and plasmids used in this
study [46,48,50,51].
(DOC)
Table S3 Primers used in S. sanguinis SK36.
aAll primers




Table S4 Primers used in S. sanguinis 133-79.
aAll
primers were designed as part of this study.
bUnderlined letters
indicate restriction enzyme site.
(DOC)
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